AAD 2023: Repigmentation Improvement Observed in Extended Use of Ruxolitinib Cream to Treat Vitiligo
Ruxolitinib cream effective and well tolerated through 104 weeks
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.